Actively Recruiting
Transplantation of Autologously Derived Mitochondria Following Ischemia
Led by Boston Children's Hospital · Updated on 2026-01-05
16
Participants Needed
1
Research Sites
512 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators propose a robust therapeutic intervention to ameliorate myocardial ischemia/ reperfusion injury and significantly decrease morbidity and mortality in patients requiring extracorporeal membrane oxygenation (ECMO), by direct injection of autogeneic mitochondria into the ischemic myocardium.
CONDITIONS
Official Title
Transplantation of Autologously Derived Mitochondria Following Ischemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric cardiology patients under the age of 18 on ECMO
- Concerns for ischemic injury in the Cardiac Intensive Care Unit
You will not qualify if you...
- Known mitochondrial disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
B
Breanna Piekarski, RN, BSN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here